Condensed Consolidated Statements of Stockholders’ Equity - USD ($) $ in Thousands | Total | Common Stock | Additional Paid-in Capital | Accumulated Other Comprehensive Loss | Accumulated Deficit |
Stockholders' Equity | | | | | |
Beginning balance | $ 480,328 | $ 16 | $ 739,503 | $ 253 | $ (259,444) |
Beginning balance (in shares) at Dec. 31, 2021 | | 164,239,555 | | | |
Stockholders' Equity | | | | | |
Issuance of common stock in connection with ESPP (in shares) | | 202,213 | | | |
Issuance of common stock in connection with ESPP | 1,882 | | 1,882 | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units (in shares) | | 1,696,601 | | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units | 2,678 | $ 1 | 2,677 | | |
Stock-based compensation expense | 9,921 | | 9,921 | | |
Other comprehensive loss | 4 | | | 4 | |
Net loss | (23,310) | | | | (23,310) |
Ending balance (in shares) at Mar. 31, 2022 | | 166,138,369 | | | |
Ending balance at Mar. 31, 2022 | 471,503 | $ 17 | 753,983 | 257 | (282,754) |
Beginning balance (in shares) at Dec. 31, 2021 | | 164,239,555 | | | |
Stockholders' Equity | | | | | |
Net loss | (94,624) | | | | |
Ending balance (in shares) at Sep. 30, 2022 | | 170,467,139 | | | |
Ending balance at Sep. 30, 2022 | 466,489 | $ 17 | 822,929 | (2,389) | (354,068) |
Stockholders' Equity | | | | | |
Beginning balance | 471,503 | $ 17 | 753,983 | 257 | (282,754) |
Beginning balance (in shares) at Mar. 31, 2022 | | 166,138,369 | | | |
Stockholders' Equity | | | | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units (in shares) | | 1,653,909 | | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units | 2,154 | | 2,154 | | |
Taxes paid related to net share settlement of equity awards (in shares) | | (2,627) | | | |
Taxes paid related to net shares settlement of equity awards | (30) | | (30) | | |
Stock-based compensation expense | 33,114 | | 33,114 | | |
Other comprehensive loss | (1,271) | | | (1,271) | |
Net loss | (38,245) | | | | (38,245) |
Ending balance (in shares) at Jun. 30, 2022 | | 167,789,651 | | | |
Ending balance at Jun. 30, 2022 | 467,225 | $ 17 | 789,221 | (1,014) | (320,999) |
Stockholders' Equity | | | | | |
Beginning balance | 467,225 | $ 17 | 789,221 | (1,014) | (320,999) |
Issuance of common stock in connection with ESPP (in shares) | | 177,461 | | | |
Issuance of common stock in connection with ESPP | 1,634 | | 1,634 | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units (in shares) | | 2,320,448 | | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units | 3,914 | | 3,914 | | |
Taxes paid related to net share settlement of equity awards (in shares) | | (2,382) | | | |
Taxes paid related to net shares settlement of equity awards | (25) | | (25) | | |
Stock-based compensation expense | 26,213 | | 26,213 | | |
Other comprehensive loss | (1,375) | | | (1,375) | |
Net loss | (33,069) | | | | (33,069) |
Ending balance (in shares) at Sep. 30, 2022 | | 170,467,139 | | | |
Ending balance at Sep. 30, 2022 | 466,489 | $ 17 | 822,929 | (2,389) | (354,068) |
Stockholders' Equity | | | | | |
Donation of common stock (in shares) | | 181,961 | | | |
Stock Issued During Period, Value, Donations | 1,972 | | 1,972 | | |
Beginning balance | 466,489 | $ 17 | 822,929 | (2,389) | (354,068) |
Beginning balance | 480,087 | $ 17 | 854,276 | (743) | (373,463) |
Beginning balance (in shares) at Dec. 31, 2022 | | 173,250,865 | | | |
Stockholders' Equity | | | | | |
Issuance of common stock in connection with ESPP (in shares) | | 297,095 | | | |
Issuance of common stock in connection with ESPP | 2,729 | | 2,729 | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units (in shares) | | 3,589,965 | | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units | 4,993 | $ 1 | 4,992 | | |
Issuance of common stock for acquisition consideration (in shares) | | 590,838 | | | |
Issuance of common stock for acquisition consideration | 6,635 | | 6,635 | | |
Issuance of common stock, subject to service-based vesting conditions, in connection with acquisition (in shares) | | 104,080 | | | |
Issuance of common stock, subject to service-based vesting conditions, in connection with acquisition | 581 | | 581 | | |
Taxes paid related to net share settlement of equity awards (in shares) | | (99,550) | | | |
Taxes paid related to net shares settlement of equity awards | (1,413) | | (1,413) | | |
Stock-based compensation expense | 29,775 | | 29,775 | | |
Other comprehensive loss | 348 | | | 348 | |
Net loss | (28,314) | | | | (28,314) |
Ending balance (in shares) at Mar. 31, 2023 | | 177,733,293 | | | |
Ending balance at Mar. 31, 2023 | 495,421 | $ 18 | 897,575 | (395) | (401,777) |
Beginning balance (in shares) at Dec. 31, 2022 | | 173,250,865 | | | |
Stockholders' Equity | | | | | |
Net loss | (82,819) | | | | |
Ending balance (in shares) at Sep. 30, 2023 | | 185,128,562 | | | |
Ending balance at Sep. 30, 2023 | 525,792 | $ 19 | 983,197 | (1,142) | (456,282) |
Stockholders' Equity | | | | | |
Beginning balance | 495,421 | $ 18 | 897,575 | (395) | (401,777) |
Beginning balance (in shares) at Mar. 31, 2023 | | 177,733,293 | | | |
Stockholders' Equity | | | | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units (in shares) | | 3,468,316 | | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units | 3,586 | | 3,586 | | |
Taxes paid related to net share settlement of equity awards (in shares) | | (39,883) | | | |
Taxes paid related to net shares settlement of equity awards | (698) | | (698) | | |
Stock-based compensation expense | 36,033 | | 36,033 | | |
Other comprehensive loss | 245 | | | 245 | |
Net loss | (18,850) | | | | (18,850) |
Ending balance (in shares) at Jun. 30, 2023 | | 181,161,726 | | | |
Ending balance at Jun. 30, 2023 | 515,737 | $ 18 | 936,496 | (150) | (420,627) |
Stockholders' Equity | | | | | |
Beginning balance | 515,737 | $ 18 | 936,496 | (150) | (420,627) |
Issuance of common stock in connection with ESPP (in shares) | | 328,272 | | | |
Issuance of common stock in connection with ESPP | 3,317 | | 3,317 | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units (in shares) | | 3,561,018 | | | |
Issuance of common stock upon exercise of stock options, including early exercised options, and vesting of restricted stock units | 3,992 | $ 1 | 3,991 | | |
Taxes paid related to net share settlement of equity awards (in shares) | | (104,415) | | | |
Taxes paid related to net shares settlement of equity awards | (2,600) | | (2,600) | | |
Stock-based compensation expense | 37,393 | | 37,393 | | |
Other comprehensive loss | (992) | | | (992) | |
Net loss | (35,655) | | | | (35,655) |
Ending balance (in shares) at Sep. 30, 2023 | | 185,128,562 | | | |
Ending balance at Sep. 30, 2023 | 525,792 | $ 19 | 983,197 | (1,142) | (456,282) |
Stockholders' Equity | | | | | |
Donation of common stock (in shares) | | 181,961 | | | |
Stock Issued During Period, Value, Donations | 4,600 | | 4,600 | | |
Beginning balance | $ 525,792 | $ 19 | $ 983,197 | $ (1,142) | $ (456,282) |